| scholarly article | Q13442814 |
| P356 | DOI | 10.1002/(SICI)1096-8628(19961122)67:6<533::AID-AJMG4>3.0.CO;2-I |
| P698 | PubMed publication ID | 8950410 |
| P2093 | author name string | Kelsoe JR | |
| Rapaport MH | |||
| Sadovnick AD | |||
| Remick RA | |||
| Spence MA | |||
| Drennan M | |||
| Bergesch P | |||
| Flodman P | |||
| Kristbjarnarson H | |||
| Mroczkowski-Parker Z | |||
| P2860 | cites work | Different chromosomal localization of two adenylyl cyclase genes expressed in human brain | Q24294426 |
| 'Touchdown' PCR to circumvent spurious priming during gene amplification | Q24630793 | ||
| Strategies for multilocus linkage analysis in humans | Q27860521 | ||
| Chromosome 18 DNA markers and manic-depressive illness: evidence for a susceptibility gene | Q28775974 | ||
| Genetic dissection of complex traits | Q29618312 | ||
| A second-generation linkage map of the human genome | Q33192755 | ||
| A diagnostic interview: the schedule for affective disorders and schizophrenia | Q34269355 | ||
| Human dopamine transporter gene (DAT1) maps to chromosome 5p15.3 and displays a VNTR. | Q34295805 | ||
| Re-evaluation of the linkage relationship between chromosome 11p loci and the gene for bipolar affective disorder in the Old Order Amish | Q34511287 | ||
| Comorbidity of attention deficit hyperactivity disorder with conduct, depressive, anxiety, and other disorders | Q34617127 | ||
| Research diagnostic criteria: rationale and reliability | Q34711463 | ||
| Cloning and expression of a cocaine-sensitive rat dopamine transporter | Q34983785 | ||
| Cloning and expression of a cocaine-sensitive dopamine transporter complementary DNA. | Q38332823 | ||
| Molecular characterization of the dopamine transporter. | Q40900564 | ||
| Evidence of familial association between attention deficit disorder and major affective disorders | Q41190001 | ||
| A linkage study of distal chromosome 5q and bipolar disorder | Q41448669 | ||
| Genetic association between dopamine transporter protein alleles and cocaine-induced paranoia | Q42280937 | ||
| A human dopamine transporter cDNA predicts reduced glycosylation, displays a novel repetitive element and provides racially-dimorphic TaqI RFLPs | Q44317448 | ||
| Status of the search for a major genetic locus for affective disorder in the Old Order Amish | Q44524764 | ||
| A genetic linkage study of bipolar disorder and 13 markers on chromosome 11 including the D2 dopamine receptor | Q46358117 | ||
| Regular induction of hypomania by L-dopa in "bipolar" manic-depressive patients | Q48853497 | ||
| Avoiding recomputation in linkage analysis. | Q52374502 | ||
| An algorithm to improve the computational efficiency of genetic linkage analysis. | Q52677152 | ||
| P433 | issue | 6 | |
| P921 | main subject | bipolar disorder | Q131755 |
| dopamine | Q170304 | ||
| P304 | page(s) | 533-540 | |
| P577 | publication date | 1996-11-01 | |
| P1433 | published in | American Journal of Medical Genetics Part A | Q15755121 |
| P1476 | title | Possible locus for bipolar disorder near the dopamine transporter on chromosome 5. | |
| P478 | volume | 67 |
| Q54601373 | A 40-basepair VNTR polymorphism in the dopamine transporter (DAT1) gene and the rapid response to antidepressant treatment. |
| Q46653202 | A dopamine transporter mutation associated with bipolar affective disorder causes inhibition of transporter cell surface expression |
| Q34620186 | A genome survey indicates a possible susceptibility locus for bipolar disorder on chromosome 22. |
| Q30480638 | A reverse-translational study of dysfunctional exploration in psychiatric disorders: from mice to men |
| Q51988728 | Alcoholism and drug abuse in three groups--bipolar I, unipolars and their acquaintances. |
| Q35236134 | Anticonvulsant drugs in bipolar disorder. |
| Q37523029 | Association of dopamine transporter gene variants with childhood ADHD features in bipolar disorder. |
| Q37219082 | Atypical antipsychotics clozapine and quetiapine attenuate prepulse inhibition deficits in dopamine transporter knockout mice |
| Q46607401 | Bipolar disorder: dominant or recessive on chromosome 5? |
| Q56972087 | Borna Disease Virus |
| Q56972248 | Borna Disease Virus |
| Q34306726 | Bornavirus tropism and targeted pathogenesis: virus-host interactions in a neurodevelopmental model |
| Q78093188 | DNA sequence polymorphisms in genes involved in the regulation of dopamine and serotonin metabolism in rhesus macaques |
| Q42126586 | Decreased Serum Hepatocyte Growth Factor (HGF) in Individuals with Bipolar Disorder Normalizes after Zinc and Anti-oxidant Therapy |
| Q34576427 | Dopamine transporter 3'-UTR VNTR genotype and ADHD: a pharmaco-behavioural genetic study with methylphenidate. |
| Q43929551 | Dopamine transporter gene (DAT1) VNTR polymorphism in major psychiatric disorders: family-based association study in the Bulgarian population |
| Q36992394 | Dopamine transporter mutant animals: a translational perspective |
| Q42701093 | Evaluation of VNTR polymorphisms of dopamine transporter gene and the risk of bipolar disorder in Zahedan, southeast Iran |
| Q33942595 | Evidence for linkage disequilibrium between the dopamine transporter and bipolar disorder. |
| Q28076564 | Excited Delirium and Sudden Death: A Syndromal Disorder at the Extreme End of the Neuropsychiatric Continuum |
| Q37662120 | Further evidence for linkage of bipolar disorder to chromosomes 6 and 17 in a new independent pedigree series |
| Q33590698 | GBR 12909 administration as a mouse model of bipolar disorder mania: mimicking quantitative assessment of manic behavior |
| Q38602930 | Genealogy Study of Three Generations of Patients with Bipolar Mood Disorder Type I. |
| Q42670819 | Genetic analysis of bipolar disorder: summary of GAW10. |
| Q57405108 | Genome-wide scan of bipolar disorder in 65 pedigrees: supportive evidence for linkage at 8q24, 18q22, 4q32, 2p12, and 13q12 |
| Q40804491 | Global variation of a 40-bp VNTR in the 3'-untranslated region of the dopamine transporter gene (SLC6A3). |
| Q37138150 | Heritability and genome-wide SNP linkage analysis of temperament in bipolar disorder |
| Q44483562 | Human dopamine transporter gene variation: effects of protein coding variants V55A and V382A on expression and uptake activities |
| Q27863301 | Human dopamine transporter gene: coding region conservation among normal, Tourette's disorder, alcohol dependence and attention-deficit hyperactivity disorder populations |
| Q46013240 | Identification of additional variants within the human dopamine transporter gene provides further evidence for an association with bipolar disorder in two independent samples. |
| Q41131309 | Identification of rare high-risk copy number variants affecting the dopamine transporter gene in mental disorders |
| Q36598826 | Increased risk-taking behavior in dopamine transporter knockdown mice: further support for a mouse model of mania |
| Q43135395 | Interaction between serotonin 5-HT2A receptor gene and dopamine transporter (DAT1) gene polymorphisms influences personality trait of persistence in Austrian Caucasians |
| Q45194112 | Lack of association between VNTR polymorphism of dopamine transporter gene (SLC6A3) and schizophrenia in a Brazilian sample |
| Q50913412 | Linkage disequilibrium between the dopamine transporter gene (DAT1) and bipolar disorder: extending the transmission disequilibrium test (TDT) to examine genetic heterogeneity. |
| Q44745561 | MDMA "ecstasy" alters hyperactive and perseverative behaviors in dopamine transporter knockout mice |
| Q34137588 | Molecular genetic and family studies in affective disorders: state of the art. |
| Q35236130 | Molecular linkage studies of bipolar disorder |
| Q34146169 | Monoamine transporter gene structure and polymorphisms in relation to psychiatric and other complex disorders |
| Q47596978 | Personality traits and dopamine receptors (D2 and D4): linkage studies in families of alcoholics |
| Q34530077 | Population isolates: their special value for locating genes for bipolar disorder |
| Q39170724 | Positive Traits in the Bipolar Spectrum: The Space between Madness and Genius |
| Q30462823 | Predictive animal models of mania: hits, misses and future directions |
| Q74205761 | Proceedings of the Genetic Analysis Workshop 10 (GAW10). Watsonville, California, USA. October 26-29, 1996 |
| Q40626256 | Promoter and intronic variants affect the transcriptional regulation of the human dopamine transporter gene |
| Q35662070 | RETRACTED: Dysregulated glutamate and dopamine transporters in postmortem frontal cortex from bipolar and schizophrenic patients |
| Q35022695 | Radiation hybrid mapping of the two highly homologous human-variant pMCHL genes by PCR-SSCP. |
| Q35295664 | Rodent versions of the iowa gambling task: opportunities and challenges for the understanding of decision-making |
| Q40661053 | Segmental linkage disequilibrium within the dopamine transporter gene |
| Q78717969 | Support for the presence of bipolar disorder susceptibility loci on chromosome 5: heterogeneity in a homogeneous population in Quebec |
| Q43728918 | Susceptibility to subsequent episodes of spontaneous recurrence of methamphetamine psychosis |
| Q57655518 | Systematic screening for DNA sequence variation in the coding region of the human dopamine transporter gene (DAT1) |
| Q35054681 | The catecholaminergic-cholinergic balance hypothesis of bipolar disorder revisited |
| Q36448838 | The influence of five monoamine genes on trajectories of depressive symptoms across adolescence and young adulthood |
| Q33886688 | The mania-like exploratory profile in genetic dopamine transporter mouse models is diminished in a familiar environment and reinstated by subthreshold psychostimulant administration |
| Q38031289 | The relationship between oxidative stress and post-translational modification of the dopamine transporter in bipolar disorder |
| Q35250553 | Understanding the genetic basis of mood disorders: where do we stand? |
| Q44315070 | Valproate attenuates hyperactive and perseverative behaviors in mutant mice with a dysregulated dopamine system |
| Q35024109 | World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of bipolar disorders. Part I: Treatment of bipolar depression |
Search more.